Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QuantiFERON-CMV for CMV Reactivation in Ulcerative Colitis
NCT04030676Recruiting
- Sponsor
- CHU Saint-Etienne
- Start
- Jul 2019
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU Saint-Etienne. Primary endpoints: Quantification of CytoMegaloVirus (CMV) DeoxyriboNucleic Acid (DNA) load and QuantiFERON-CytoMegaloVirus (QF-CMV) test result. Started Jul 2019; status: recruiting.
Beyond the preview
Go deeper on NCT04030676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030676.